Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Xenon, Xe-133

CompanyCurium US LLC (DUNS: 079875617)

Effective Date

December 15, 2022

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Xenon-133(5 mCi in 1 mL)

Products (2)

Xenon, Xe-133

NDC Product Code

69945-097

Application Number

NDA018327

Marketing Category

NDA (C73594)

Route of Administration

RESPIRATORY (INHALATION)

Effective Date

December 15, 2022

Ingredients

Xenon-133Active

Code: X3P9A5HNYFClass: ACTIBQuantity: 5 mCi in 1 mL

AIRInactive

Code: K21NZZ5Y0BClass: IACT

Xenon, Xe-133

NDC Product Code

69945-098

Application Number

NDA018327

Marketing Category

NDA (C73594)

Route of Administration

RESPIRATORY (INHALATION)

Effective Date

December 15, 2022

Ingredients

Xenon-133Active

Code: X3P9A5HNYFClass: ACTIBQuantity: 10 mCi in 1 mL

AIRInactive

Code: K21NZZ5Y0BClass: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy